Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200253304> ?p ?o ?g. }
- W4200253304 endingPage "396" @default.
- W4200253304 startingPage "381" @default.
- W4200253304 abstract "Tumor- and bone-derived soluble factors have been proposed to participate in the alterations of skeletal muscle size and function in cachexia. We previously showed that mice bearing ovarian cancer (OvCa) exhibit cachexia associated with marked bone loss, whereas bone-targeting agents, such as bisphosphonates, are able to preserve muscle mass in animals exposed to anticancer drugs. De-identified CT images and plasma samples from female patients affected with OvCa were used for body composition assessment and quantification of circulating cross-linked C-telopeptide type I (CTX-I) and receptor activator of NF-kB ligand (RANKL), respectively. Female mice bearing ES-2 tumors were used to characterize cancer- and RANKL-associated effects on muscle and bone. Murine C2C12 and human HSMM myotube cultures were used to determine the OvCa- and RANKL-dependent effects on myofiber size. To the extent of isolating new regulators of bone and muscle in cachexia, here we demonstrate that subjects affected with OvCa display evidence of cachexia and increased bone turnover. Similarly, mice carrying OvCa present high RANKL levels. By using in vitro and in vivo experimental models, we found that elevated circulating RANKL is sufficient to cause skeletal muscle atrophy and bone resorption, whereas bone preservation by means of antiresorptive and anti-RANKL treatments concurrently benefit muscle mass and function in cancer cachexia. Altogether, our data contribute to identifying RANKL as a novel therapeutic target for the treatment of musculoskeletal complications associated with RANKL-expressing non-metastatic cancers. © 2021 American Society for Bone and Mineral Research (ASBMR)." @default.
- W4200253304 created "2021-12-31" @default.
- W4200253304 creator A5014708424 @default.
- W4200253304 creator A5029880299 @default.
- W4200253304 creator A5044025817 @default.
- W4200253304 creator A5062132023 @default.
- W4200253304 creator A5062765378 @default.
- W4200253304 creator A5069864604 @default.
- W4200253304 creator A5088760759 @default.
- W4200253304 date "2021-12-13" @default.
- W4200253304 modified "2023-10-10" @default.
- W4200253304 title "<scp>RANKL</scp> Blockade Reduces Cachexia and Bone Loss Induced by Non‐Metastatic Ovarian Cancer in Mice" @default.
- W4200253304 cites W139851679 @default.
- W4200253304 cites W1502767888 @default.
- W4200253304 cites W1528788646 @default.
- W4200253304 cites W1533900546 @default.
- W4200253304 cites W1896432851 @default.
- W4200253304 cites W1946529897 @default.
- W4200253304 cites W1960633973 @default.
- W4200253304 cites W1972842664 @default.
- W4200253304 cites W1974660371 @default.
- W4200253304 cites W1977753585 @default.
- W4200253304 cites W1980224053 @default.
- W4200253304 cites W1985645291 @default.
- W4200253304 cites W1997338647 @default.
- W4200253304 cites W2001372146 @default.
- W4200253304 cites W2001609376 @default.
- W4200253304 cites W2003064100 @default.
- W4200253304 cites W2003158625 @default.
- W4200253304 cites W2004943901 @default.
- W4200253304 cites W2017211434 @default.
- W4200253304 cites W2018450474 @default.
- W4200253304 cites W2020541351 @default.
- W4200253304 cites W2022509414 @default.
- W4200253304 cites W2025669441 @default.
- W4200253304 cites W2039318456 @default.
- W4200253304 cites W2044511370 @default.
- W4200253304 cites W2047401364 @default.
- W4200253304 cites W2049293744 @default.
- W4200253304 cites W2051255001 @default.
- W4200253304 cites W2060482009 @default.
- W4200253304 cites W2076668534 @default.
- W4200253304 cites W2084515449 @default.
- W4200253304 cites W2101398993 @default.
- W4200253304 cites W2105818146 @default.
- W4200253304 cites W2114104545 @default.
- W4200253304 cites W2117996911 @default.
- W4200253304 cites W2118385824 @default.
- W4200253304 cites W2124036292 @default.
- W4200253304 cites W2133233871 @default.
- W4200253304 cites W2134976449 @default.
- W4200253304 cites W2138207763 @default.
- W4200253304 cites W2145280166 @default.
- W4200253304 cites W2152816976 @default.
- W4200253304 cites W2157644555 @default.
- W4200253304 cites W2169456326 @default.
- W4200253304 cites W2170680219 @default.
- W4200253304 cites W2171249989 @default.
- W4200253304 cites W2195625763 @default.
- W4200253304 cites W2225078923 @default.
- W4200253304 cites W2291867385 @default.
- W4200253304 cites W2313316194 @default.
- W4200253304 cites W2415024679 @default.
- W4200253304 cites W2432815617 @default.
- W4200253304 cites W2551593933 @default.
- W4200253304 cites W2557277725 @default.
- W4200253304 cites W2561257891 @default.
- W4200253304 cites W2573152477 @default.
- W4200253304 cites W2573888447 @default.
- W4200253304 cites W2575793504 @default.
- W4200253304 cites W2736730167 @default.
- W4200253304 cites W2765858004 @default.
- W4200253304 cites W2778172366 @default.
- W4200253304 cites W2782778013 @default.
- W4200253304 cites W2800829257 @default.
- W4200253304 cites W2884193995 @default.
- W4200253304 cites W2945104186 @default.
- W4200253304 cites W2945787015 @default.
- W4200253304 cites W2948654084 @default.
- W4200253304 cites W2950484602 @default.
- W4200253304 cites W2953943341 @default.
- W4200253304 cites W2963480105 @default.
- W4200253304 cites W2990516442 @default.
- W4200253304 cites W2998887343 @default.
- W4200253304 cites W2999417355 @default.
- W4200253304 cites W3003994673 @default.
- W4200253304 cites W3014503570 @default.
- W4200253304 cites W3017366298 @default.
- W4200253304 cites W3024249113 @default.
- W4200253304 cites W3025061155 @default.
- W4200253304 cites W3043007125 @default.
- W4200253304 cites W3101368019 @default.
- W4200253304 cites W3153396515 @default.
- W4200253304 cites W3181384530 @default.
- W4200253304 doi "https://doi.org/10.1002/jbmr.4480" @default.
- W4200253304 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34904285" @default.
- W4200253304 hasPublicationYear "2021" @default.
- W4200253304 type Work @default.